A Study of the Cardiac Effects of Danicopan in Healthy Adults

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

This was a randomized, double-blind, double-dummy, placebo- and positive-controlled, 2-arm (Treatment Arm and Control Arm), parallel study to evaluate the effect of ACH-0144471 (danicopan) on the QT interval in healthy adult participants.

Key facts

Study ID
NCT05016206
Run by
Alexion Pharmaceuticals, Inc.
People needed
33
Starts
2018-07-26
Expected to finish
2018-10-12
Last updated by the study team
2021-08-23

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.